Found: 40
Select item for more details and to access through your institution.
Addition of glucagon‐like peptide‐1 receptor agonist therapy to insulin in C‐peptide‐positive patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1054, doi. 10.1111/dom.13609
- By:
- Publication type:
- Article
Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post‐hoc analysis of the DURATION‐3 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1049, doi. 10.1111/dom.13606
- By:
- Publication type:
- Article
The effects of incretin‐based therapies on β‐cell function and insulin resistance in type 2 diabetes: A systematic review and network meta‐analysis combining 360 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 975, doi. 10.1111/dom.13613
- By:
- Publication type:
- Article
A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1043, doi. 10.1111/dom.13598
- By:
- Publication type:
- Article
Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 772, doi. 10.1111/dom.13601
- By:
- Publication type:
- Article
Cover Image, Volume 21, Issue 4.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. i, doi. 10.1111/dom.13688
- By:
- Publication type:
- Article
Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1027, doi. 10.1111/dom.13631
- By:
- Publication type:
- Article
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1066, doi. 10.1111/dom.13621
- By:
- Publication type:
- Article
The renoprotective effects of sodium‐glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1018, doi. 10.1111/dom.13620
- By:
- Publication type:
- Article
Largest single‐centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1061, doi. 10.1111/dom.13619
- By:
- Publication type:
- Article
Cost‐effectiveness of intensification with sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1010, doi. 10.1111/dom.13618
- By:
- Publication type:
- Article
Stability of insulin and C‐peptide measurement with long‐term frozen storage of serum: Implications for diabetes research studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1058, doi. 10.1111/dom.13617
- By:
- Publication type:
- Article
A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1001, doi. 10.1111/dom.13616
- By:
- Publication type:
- Article
Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 993, doi. 10.1111/dom.13615
- By:
- Publication type:
- Article
Comparative effectiveness and harms of long‐acting insulins for type 1 and type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 984, doi. 10.1111/dom.13614
- By:
- Publication type:
- Article
Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48‐week, multi‐centre, randomized, controlled trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 939, doi. 10.1111/dom.13605
- By:
- Publication type:
- Article
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 968, doi. 10.1111/dom.13612
- By:
- Publication type:
- Article
A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 961, doi. 10.1111/dom.13610
- By:
- Publication type:
- Article
A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12‐week, single‐blind, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 930, doi. 10.1111/dom.13604
- By:
- Publication type:
- Article
Cardiac metabolic modulation upon low‐carbohydrate low‐protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized <sup>13</sup>C pyruvate, butyrate and acetoacetate probes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 949, doi. 10.1111/dom.13608
- By:
- Publication type:
- Article
Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 909, doi. 10.1111/dom.13602
- By:
- Publication type:
- Article
PCSK9 inhibitor therapy: A systematic review and meta‐analysis of metabolic and cardiovascular outcomes in patients with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 903, doi. 10.1111/dom.13599
- By:
- Publication type:
- Article
Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 920, doi. 10.1111/dom.13603
- By:
- Publication type:
- Article
Exenatide use and incidence of pancreatic and thyroid cancer: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1037, doi. 10.1111/dom.13597
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 747, doi. 10.1111/dom.13428
- Publication type:
- Article
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 761, doi. 10.1111/dom.13596
- By:
- Publication type:
- Article
Identification of autoimmune type 1 diabetes and multiple organ‐specific autoantibodies in adult‐onset non‐insulin‐requiring diabetes in China: A population‐based multicentre nationwide survey.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 893, doi. 10.1111/dom.13595
- By:
- Publication type:
- Article
Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 883, doi. 10.1111/dom.13594
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 876, doi. 10.1111/dom.13593
- By:
- Publication type:
- Article
Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 749, doi. 10.1111/dom.13592
- By:
- Publication type:
- Article
Liraglutide pharmacotherapy reduces body weight and improves glycaemic control in juvenile obese/hyperglycaemic male and female rats.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 866, doi. 10.1111/dom.13591
- By:
- Publication type:
- Article
Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase‐4 inhibitors: An analysis of Medicare claims data from 2007 to 2015.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 854, doi. 10.1111/dom.13589
- By:
- Publication type:
- Article
Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 844, doi. 10.1111/dom.13588
- By:
- Publication type:
- Article
Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 837, doi. 10.1111/dom.13587
- By:
- Publication type:
- Article
Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 829, doi. 10.1111/dom.13586
- By:
- Publication type:
- Article
DREAM5: An open‐label, randomized, cross‐over study to evaluate the safety and efficacy of day and night closed‐loop control by comparing the MD‐Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 822, doi. 10.1111/dom.13585
- By:
- Publication type:
- Article
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 812, doi. 10.1111/dom.13584
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 801, doi. 10.1111/dom.13577
- By:
- Publication type:
- Article
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 791, doi. 10.1111/dom.13575
- By:
- Publication type:
- Article
Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 781, doi. 10.1111/dom.13574
- By:
- Publication type:
- Article